Cargando…
Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses
The study of screening active constituents from traditional Chinese medicine (TCM) is important for explicating the mechanism of action of TCM and further evaluating the safety and efficacy effectively. However, detecting and identifying the active constituents from complicated biological samples st...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666879/ https://www.ncbi.nlm.nih.gov/pubmed/34912220 http://dx.doi.org/10.3389/fphar.2021.759157 |
_version_ | 1784614286895611904 |
---|---|
author | Yang, Wenning Jiang, Xiaoquan Liu, Jingtong Qi, Dongying Luo, Zhiqiang Yu, Guohua Li, Xueyan Sen, Muli Chen, Hongjiao Liu, Wei Liu, Yang Wang, Guopeng |
author_facet | Yang, Wenning Jiang, Xiaoquan Liu, Jingtong Qi, Dongying Luo, Zhiqiang Yu, Guohua Li, Xueyan Sen, Muli Chen, Hongjiao Liu, Wei Liu, Yang Wang, Guopeng |
author_sort | Yang, Wenning |
collection | PubMed |
description | The study of screening active constituents from traditional Chinese medicine (TCM) is important for explicating the mechanism of action of TCM and further evaluating the safety and efficacy effectively. However, detecting and identifying the active constituents from complicated biological samples still remain a challenge. Here, a practical, quick, and novel integrated strategy from in vitro, in situ, in vivo to in silico for rapidly screening the active constituents was developed. Firstly, the chemical profile of TCM in vitro was identified using UPLC-Q Exactive-Orbitrap HRMS. Secondly, the in situ intestinal perfusion with venous sampling (IPVS) method was used to investigate the intestinal absorption components. Thirdly, after intragastric administration of the TCM extract, the in vivo absorbed prototype components were detected and identified. Finally, the target network pharmacology approach was applied to explore the potential targets and possible mechanisms of the absorbed components from TCM. The reliability and availability of this approach was demonstrated using Tongfengding capsule (TFDC) as an example of herbal medicine. A total of 141 compounds were detected and identified in TFDC, and among them, 64 components were absorbed into the plasma. Then, a total of 35 absorbed bioactive components and 50 related targets shared commonly by compounds and gout were integrated via target network pharmacology analysis. Ultimately, the effects of the absorbed components on metabolism pathways were verified by experiments. These results demonstrated that this original method may provide a practical tool for screening bioactive compounds from TCM treating particular diseases. Furthermore, it also can clarify the potential mechanism of action of TCM and rationalize the application of TFDC as an effective herbal therapy for gout. |
format | Online Article Text |
id | pubmed-8666879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86668792021-12-14 Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses Yang, Wenning Jiang, Xiaoquan Liu, Jingtong Qi, Dongying Luo, Zhiqiang Yu, Guohua Li, Xueyan Sen, Muli Chen, Hongjiao Liu, Wei Liu, Yang Wang, Guopeng Front Pharmacol Pharmacology The study of screening active constituents from traditional Chinese medicine (TCM) is important for explicating the mechanism of action of TCM and further evaluating the safety and efficacy effectively. However, detecting and identifying the active constituents from complicated biological samples still remain a challenge. Here, a practical, quick, and novel integrated strategy from in vitro, in situ, in vivo to in silico for rapidly screening the active constituents was developed. Firstly, the chemical profile of TCM in vitro was identified using UPLC-Q Exactive-Orbitrap HRMS. Secondly, the in situ intestinal perfusion with venous sampling (IPVS) method was used to investigate the intestinal absorption components. Thirdly, after intragastric administration of the TCM extract, the in vivo absorbed prototype components were detected and identified. Finally, the target network pharmacology approach was applied to explore the potential targets and possible mechanisms of the absorbed components from TCM. The reliability and availability of this approach was demonstrated using Tongfengding capsule (TFDC) as an example of herbal medicine. A total of 141 compounds were detected and identified in TFDC, and among them, 64 components were absorbed into the plasma. Then, a total of 35 absorbed bioactive components and 50 related targets shared commonly by compounds and gout were integrated via target network pharmacology analysis. Ultimately, the effects of the absorbed components on metabolism pathways were verified by experiments. These results demonstrated that this original method may provide a practical tool for screening bioactive compounds from TCM treating particular diseases. Furthermore, it also can clarify the potential mechanism of action of TCM and rationalize the application of TFDC as an effective herbal therapy for gout. Frontiers Media S.A. 2021-11-29 /pmc/articles/PMC8666879/ /pubmed/34912220 http://dx.doi.org/10.3389/fphar.2021.759157 Text en Copyright © 2021 Yang, Jiang, Liu, Qi, Luo, Yu, Li, Sen, Chen, Liu, Liu and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yang, Wenning Jiang, Xiaoquan Liu, Jingtong Qi, Dongying Luo, Zhiqiang Yu, Guohua Li, Xueyan Sen, Muli Chen, Hongjiao Liu, Wei Liu, Yang Wang, Guopeng Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses |
title | Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses |
title_full | Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses |
title_fullStr | Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses |
title_full_unstemmed | Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses |
title_short | Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses |
title_sort | integrated strategy from in vitro, in situ, in vivo to in silico for predicting active constituents and exploring molecular mechanisms of tongfengding capsule for treating gout by inhibiting inflammatory responses |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666879/ https://www.ncbi.nlm.nih.gov/pubmed/34912220 http://dx.doi.org/10.3389/fphar.2021.759157 |
work_keys_str_mv | AT yangwenning integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT jiangxiaoquan integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT liujingtong integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT qidongying integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT luozhiqiang integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT yuguohua integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT lixueyan integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT senmuli integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT chenhongjiao integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT liuwei integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT liuyang integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses AT wangguopeng integratedstrategyfrominvitroinsituinvivotoinsilicoforpredictingactiveconstituentsandexploringmolecularmechanismsoftongfengdingcapsulefortreatinggoutbyinhibitinginflammatoryresponses |